EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026

2017-06-01
Price :
Published : Jun-2017
No. of Pages : 36
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Executive Summary 4
2.1 Related Reports 5
2.2 Upcoming Reports 6
3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 8
3.3 Global and Historical Trends 9
3.3.1 GHD in children 10
3.3.2 GHD in adults 11
3.4 Forecast Methodology 11
3.4.1 Sources 13
3.4.2 Forecast Assumptions and Methods 16
3.5 Epidemiological Forecast for GHD (2016-2026) 22
3.5.1 Diagnosed Prevalent Cases of GHD 22
3.5.2 Age-Specific Diagnosed Prevalent Cases of GHD 23
3.5.3 Sex-Specific Diagnosed Prevalent Cases of GHD 24
3.5.4 Idiopathic and Organic GHD in Children 25
3.5.5 Congenital and Acquired GHD Out of Organic GHD in Children 26
3.5.6 Idiopathic and Acquired GHD in Adults 27
3.5.7 Onset Timing 28
3.6 Discussion 29
3.6.1 Epidemiological Forecast Insight 29
3.6.2 Limitations of Analysis 30
3.6.3 Strengths of the Analysis 30
4 Appendix 31
4.1 Bibliography 31
4.2 About the Authors 34
4.2.1 Epidemiologist 34
4.2.2 Reviewers 34
4.2.3 Global Director of Therapy Analysis and Epidemiology 35
4.2.4 Global Head and EVP of Healthcare Operations and Strategy 35
4.3 About GlobalData 36
4.4 Contact Us 36
4.5 Disclaimer 36

1.1 List of Tables
Table 1: Risk Factors and Comorbidities for GHD 8
Table 2: Diagnosed Prevalent Cases of GHD, Men and Women, All Ages, for 2016-2026. 22

1.2 List of Figures
Figure 1: 7MM, Diagnosed Prevalent Cases of GHD, Both Sexes, All Ages, 2016 and 2026 5
Figure 2: Age-Standardized Diagnosed Prevalence of GHD, Men and Women, All Ages, 2016 10
Figure 3: Case Flow Map of GHD 12
Figure 4: Sources Used and Not Used for the Diagnosed Prevalent Cases of GHD in Children 13
Figure 5: Sources Used and Not Used in the Forecast for Diagnosed Prevalent Cases of GHD in Adults 13
Figure 6 Sources Used and Not Used in the Forecast for Type of GHD in Children 14
Figure 7 Sources Used and Not Used in the Forecast for Type of GHD in Adults 15
Figure 8 Sources Used and Not Used in the Forecast for Onset Timing of GHD in Adults 16
Figure 9: Age-Specific Diagnosed Prevalent Cases of GHD, Men and Women, All Ages, 2016. 23
Figure 10: Sex-Specific Diagnosed Prevalent Cases, Men, Women, All Ages, 2016 24
Figure 11: Diagnosed Prevalent Cases of GHD in Children Segmented into Idiopathic and Organic GHD, Boys and Girls, Ages ?18 years, 2016 25
Figure 12: Diagnosed Prevalent Cases of Congenital or Acquired GHD Out of Organic GHD, Boys and Girls, Ages ?18 years, 2016 26
Figure 13: Idiopathic and Acquired GHD in Adults, Men and Women, Ages ?19 Years, 2016. 27
Figure 14: Diagnosed Prevalent Cases by Onset Timing, Men and Women, Ages ?19 Years, 2016. 28
Filed in: Pharmaceutical
Publisher : GlobalData